Navigation Links
First corneal transplant with pre-loaded donor tissue performed at Mass. Eye and Ear
Date:5/7/2013

Boston (May 7, 2013) The first successful cornea transplant with donor endothelial tissue preloaded by an eye bank has been performed at Massachusetts Eye and Ear in Boston, Mass. Roberto Pineda II, M.D., Director of the Refractive Surgery Service at Mass. Eye and Ear, and an Associate Professor of Ophthalmology at Harvard Medical School, recently performed the groundbreaking transplant.

Dr. Pineda performed the surgery utilizing donor endothelial tissue that was prepared and pre-loaded into EndoGlide (Angiotech Pharmaceuticals, Inc.) cartridges at the Lions Eye Institute for Transplant & Research (LEITR) in Tampa, FL.

According to Dr. Pineda, using preloaded donor tissue may minimize potential damage to the endothelial cells and, thus, may lead to better outcomes for the patient.

"Reducing any variables that could interfere with a patient's ability to successfully regain sight after surgery is significant," said Dr. Pineda. "The ultimate goal is to improve the quality of life for our patients," Dr. Pineda said.

A world-leading cornea expert and refractive surgeon at Mass. Eye and Ear, Dr. Pineda has collaborated with LEITR and Angiotech/Sharpoint for the last seven months to help develop the innovative procedure.

"I am pleased that - with Dr. Pineda leading these efforts - Mass. Eye and Ear is at the forefront of implementing an innovative technology that could greatly improve the quality of surgical outcomes for patients facing partial or complete vision loss," said Joan W. Miller, M.D., FARVO, Chief and Chair of Ophthalmology at Mass. Eye and Ear and Harvard Medical School.

Last year, LEITR reported that eye banks are able to safely prepare and load corneal tissue into the EndoGlide cartridges. In a pre-clinical study presented at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, corneal buttons pre-loaded by LEITR sustained an average of 9.07% endothelial cell damage, compared to 36.2% endothelial cell damage in control group tissue that was loaded into the insertion system on site. The difference in endothelial damage between the preloaded and control buttons was statistically significant (P = 0.004).


'/>"/>

Contact: Vannessa Carrington
vannessa_carrington@meei.harvard.du
617-573-3341
Massachusetts Eye and Ear Infirmary
Source:Eurekalert

Related medicine news :

1. McAdams DeMarco Awarded $100,000 as First Arthritis-Aging Collaborative Researcher
2. DocVerify and Wufoo Release First One Click Electronic Signature Web Form Add-On
3. Power Up For Profits! Client Releases First Book at the Age of 71
4. The Discovery House Hosts First Alumni Meeting
5. NFL Kicker Billy Cundiff Launches Kicking For The Dream to Celebrate First World Ovarian Cancer Day, May 08, 2013
6. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Scheduling of First Bellwether Trial in New Jersey C.R. Bard Pelvic Mesh Litigation
7. Health First and Palm Bay Police Department Receive National Recognition for Innovative Telemedicine Project to Help Patients Before they Get to the Hospital
8. Actos Lawyers at Bernstein Liebhard LLP Comment on California Judge’s Decision to Set Aside Verdict in Nation’s First Actos Bladder Cancer Trial
9. First Choice Emergency Room Partners with 99.5 The Wolf to Giveaway Kenny Chesney Concert Tickets
10. Schuylkill Medical Associates Announces Partnership with Integrity First Consulting
11. The Republic of Tea Introduces 2013 First Flush Darjeeling Full-Leaf Organic, Rainforest Alliance Certified™ Tea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... , ... At Hallmark Nameplate, their commitment to quality is what sets them ... 13485. This certification is another way they are making constant strides to provide all ... need. , The ISO 13485 Certification is a major accomplishment for Hallmark Nameplate and ...
(Date:1/18/2017)... ... January 18, 2017 , ... Michael J. Hennessy ... for its Center for Biosimilars, announced Michael J. Hennessy Associates, Inc. President Michael ... field of biosimilars through thought leader interaction in, live video and interactive digital ...
(Date:1/18/2017)... ... 18, 2017 , ... During pregnancy, women are at an ... those dental problems can increase the risk of pregnancy complications. Unfortunately, according to ... to get the dental care they need. Agoura Hills dentist, Philip Shindler ...
(Date:1/17/2017)... , ... January 17, 2017 , ... Anesthesia Progress ... for dentists to choose the best drug option for each patient. Dentists have several ... and better overall outcomes. , Researchers from the Tokyo Dental College in Tokyo, Japan ...
(Date:1/17/2017)... ... 17, 2017 , ... For breast cancer clinicians and researchers who were unable ... a more intimate review and analysis of its highlights, a novel half-day, complimentary meeting—the ... by Imedex on February 4, 2017 in Chicago. Chaired by Kathy S. Albain, MD, ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017  Dermata Therapeutics, LLC, ... to treat a variety of dermatological diseases, announces ... DMT210, in a Phase 2 acne rosacea study. ... downregulate the proinflammatory cytokines in the skin responsible ... rosacea. This clinical trial, DMT210-003, ...
(Date:1/18/2017)... Safe Rx LLC and Good Day Pharmacy, ... Loveland, Colorado , today announced the availability ... Day locations.     "Patients with prescriptions prone ... storage," said Milton Cohen , President & CEO ... a cup of coffee, you can protect your children ...
(Date:1/18/2017)... In China , we say Health is ... China,s Healthy Strategy originates. 2016 is ... and Social Development of the People,s Republic of ... council of the People,s Republic of China ... plan, identifying medical devices as one of the main breakthrough ...
Breaking Medicine Technology: